rs1824682
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001384474.1(LOXHD1):c.2048-102A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.231 in 892,746 control chromosomes in the GnomAD database, including 25,623 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 6183 hom., cov: 32)
Exomes 𝑓: 0.22 ( 19440 hom. )
Consequence
LOXHD1
NM_001384474.1 intron
NM_001384474.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.04
Publications
3 publications found
Genes affected
LOXHD1 (HGNC:26521): (lipoxygenase homology PLAT domains 1) This gene encodes a highly conserved protein consisting entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains, thought to be involved in targeting proteins to the plasma membrane. Studies in mice show that this gene is expressed in the mechanosensory hair cells in the inner ear, and mutations in this gene lead to auditory defects, indicating that this gene is essential for normal hair cell function. Screening of human families segregating deafness identified a mutation in this gene which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL). Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Mar 2010]
LOXHD1 Gene-Disease associations (from GenCC):
- autosomal recessive nonsyndromic hearing loss 77Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Fuchs' endothelial dystrophyInheritance: AD Classification: LIMITED Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 18-46569740-T-C is Benign according to our data. Variant chr18-46569740-T-C is described in ClinVar as Benign. ClinVar VariationId is 1184659.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.403 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LOXHD1 | NM_001384474.1 | c.2048-102A>G | intron_variant | Intron 15 of 40 | ENST00000642948.1 | NP_001371403.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LOXHD1 | ENST00000642948.1 | c.2048-102A>G | intron_variant | Intron 15 of 40 | NM_001384474.1 | ENSP00000496347.1 | ||||
| LOXHD1 | ENST00000536736.5 | c.2048-102A>G | intron_variant | Intron 15 of 39 | 5 | ENSP00000444586.1 | ||||
| LOXHD1 | ENST00000441551.6 | c.2048-102A>G | intron_variant | Intron 15 of 38 | 5 | ENSP00000387621.2 | ||||
| LOXHD1 | ENST00000335730.6 | n.1361-102A>G | intron_variant | Intron 8 of 26 | 2 |
Frequencies
GnomAD3 genomes AF: 0.266 AC: 40458AN: 151908Hom.: 6150 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
40458
AN:
151908
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.224 AC: 166026AN: 740720Hom.: 19440 AF XY: 0.225 AC XY: 83935AN XY: 372988 show subpopulations
GnomAD4 exome
AF:
AC:
166026
AN:
740720
Hom.:
AF XY:
AC XY:
83935
AN XY:
372988
show subpopulations
African (AFR)
AF:
AC:
7518
AN:
18118
American (AMR)
AF:
AC:
3332
AN:
21378
Ashkenazi Jewish (ASJ)
AF:
AC:
3915
AN:
15542
East Asian (EAS)
AF:
AC:
2070
AN:
32232
South Asian (SAS)
AF:
AC:
12009
AN:
47436
European-Finnish (FIN)
AF:
AC:
6222
AN:
40498
Middle Eastern (MID)
AF:
AC:
826
AN:
2594
European-Non Finnish (NFE)
AF:
AC:
121759
AN:
527510
Other (OTH)
AF:
AC:
8375
AN:
35412
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
6181
12361
18542
24722
30903
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3282
6564
9846
13128
16410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.267 AC: 40550AN: 152026Hom.: 6183 Cov.: 32 AF XY: 0.260 AC XY: 19302AN XY: 74324 show subpopulations
GnomAD4 genome
AF:
AC:
40550
AN:
152026
Hom.:
Cov.:
32
AF XY:
AC XY:
19302
AN XY:
74324
show subpopulations
African (AFR)
AF:
AC:
16902
AN:
41438
American (AMR)
AF:
AC:
3130
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
856
AN:
3468
East Asian (EAS)
AF:
AC:
383
AN:
5174
South Asian (SAS)
AF:
AC:
1165
AN:
4816
European-Finnish (FIN)
AF:
AC:
1701
AN:
10586
Middle Eastern (MID)
AF:
AC:
83
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15478
AN:
67948
Other (OTH)
AF:
AC:
577
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1412
2824
4236
5648
7060
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
400
800
1200
1600
2000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
661
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 77 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.